Articles By Olga Petryna, MD
Emerging Therapies in Spondyloarthritis: A Promising Pipeline
By Olga Petryna, MD
24 November 2021
Growing awareness of spondyloarthropathies over the last two decades has led to a better understanding of the pathophysiology of spondyloarthritis, and subsequently increased interest in more distinct, disease state specific treatment options.
Read Article
Infection or Disease Flare: What Tools Can Help Differentiate?
By Olga Petryna, MD
08 November 2021
Differentiation between a flare of disease and infection in patients with autoinflammatory (AI) conditions, where fever is the hallmark, can be extremely difficult. Few studies have evaluated potential differentiators; and having such tools would meet a huge unmet need.
Read ArticleEmerging Therapies in Spondyloarthritis: A Promising Pipeline
By Olga Petryna, MD
06 November 2021
Growing awareness of spondyloarthropathies over the last two decades has led to a better understanding of the pathophysiology of spondyloarthritis, and subsequently increased interest in more distinct, disease state specific treatment options.
Read Article
Liver Management in Rheumatoid Arthritis - RNL2021 Highlight
By Olga Petryna, MD
22 March 2021
While rheumatoid arthritis (RA) is not known to affect the liver directly, underlying liver disease and treatment-related effects on the liver can often become an obstacle in the management of many RA patients. In his Sunday presentation at RNL2021, Dr.
Read Article
Pegloticase in Severe Refractory Gout
By Olga Petryna, MD
25 November 2020
Listen as Dr. Petryna reviews abstracts #0683 (Pharmacokinetics of Pegloticase and Methotrexate Polyglutamate(s) in Patients with Uncontrolled Gout Receiving Pegloticase and Co-treatment of Methotrexate) and #0677 (A Multicenter, Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled GOut Receiving Pegloticase (MIRROR): 12-Month Results of an Open-Label Study) from the 2020 ACR meeting.
Read Article
Diagnostic tools in autoinflammatory syndromes
By Olga Petryna, MD
10 November 2020
With broader awareness about the disease state, early diagnosis and treatment in autoinflammatory syndromes, and its life threatening complication Macrophage Activation Syndrome, remains a huge unmet need.
Read Article
Diagnostic Delay in Psoriatic Arthritis: What are the Consequences?
By Olga Petryna, MD
06 November 2020
Despite increased awareness and better diagnostic modalities at hand, early diagnosis of psoriatic arthritis (PsA) still remains a huge unmet need.
Read Article
Are we doing our best treating seronegative arthritides?
By Olga Petryna, MD
09 June 2020
Every time a big scientific meeting ends I ask myself a question: how is it going to affect the way I treat my patients? This year the question pertains to management of axial spondyloarthropathies and psoriatic arthritis.
Read Article
Pegradicase+ImmTOR SEL-212 Shows Promising Results In Active Gout
By Olga Petryna, MD
25 November 2019
Therapies targeting sUA accumulation or improving its excretion are widely used for treatment of symptoms and prevention of progression of gout for decades.
Read Article
PANLAR Ultrasound Study Group: Recommendations On Imaging Modalities In Gout
By Olga Petryna, MD
20 November 2019
Gout is a systemic inflammatory disease with high potential for joint damage due to erosive changes and MSU deposits resulting in disability and chronic pain. Prompt diagnosis and effective treatment are key to better long term outcomes and decreased disability.
Read Article